Business
Sanofi and Regeneron Expand Partnership
Pharmaceutical giants Sanofi and Regeneron have extended their collaboration, capitalizing on the success of Dupixent. The deal aims to further develop their joint projects.
Coverage timeline — 1 article
STAT News
Sanofi and Regeneron have re-upped their collaboration pact, aiming to build on the blockbuster success of the drug Dupixent.
2026-10-01 06:16 UTC